Cargando…

Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions

BACKGROUND: Subanesthetic ketamine infusions can elicit rapid and sustained antidepressant effects, yet the potential cognitive impact of ketamine has not been thoroughly examined. This study measured changes in objective and subjective cognitive function following repeated ketamine treatment. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Jennifer L, Van Geel, Amanda, Burhunduli, Patricia, Vasudev, Dominique, Batten, Lisa A, Norris, Sandhaya, Talbot, Jeanne, Ortiz, Abigail, Owoeye, Olabisi, Blier, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743964/ https://www.ncbi.nlm.nih.gov/pubmed/35931041 http://dx.doi.org/10.1093/ijnp/pyac045

Ejemplares similares

PS222. Ketamine Exerts a Prolonged Reduction in Suicidal Ideation Independent of its Antidepressant Effects
por: Phillips, Jennifer L., et al.
Publicado: (2016)

Repeated but Not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons
por: Iro, Chidiebere M, et al.
Publicado: (2021)

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
por: Zuilhof, Zoë, et al.
Publicado: (2018)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Corrigendum to: Repeated but not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons
por: Iro, Chidiebere M, et al.
Publicado: (2021)

On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods
por: Strong, C.E., et al.
Publicado: (2018)

Functional Dysconnectivity of Frontal Cortex to Striatum Predicts Ketamine Infusion Response in Treatment-Resistant Depression
por: Chen, Mu-Hong, et al.
Publicado: (2020)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine-lidocaine infusions in conscious dogs
por: Kaka, Ubedullah, et al.
Publicado: (2016)

Medical assistance in living after failure of ECT and ketamine
por: Lafrenière, Simon, et al.
Publicado: (2022)

Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression
por: Lin, Wei-Chen, et al.
Publicado: (2023)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
por: Zhan, Yanni, et al.
Publicado: (2020)

Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
por: Zheng, Wei, et al.
Publicado: (2020)

Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
por: Rosenblat, Joshua D., et al.
Publicado: (2021)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
por: Chisamore, Noah, et al.
Publicado: (2023)

A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation
por: Su, Tung-Ping, et al.
Publicado: (2023)

Utilization of Psychiatric Team Driven Ketamine Infusions
por: Ithman, M., et al.
Publicado: (2022)

Increased Demand for Ketamine Infusions and Associated Complexities
por: Peskin, Evan, et al.
Publicado: (2023)

Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review
por: Dai, Danika, et al.
Publicado: (2022)

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
por: Price, Rebecca B., et al.
Publicado: (2022)

(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
por: Ago, Yukio, et al.
Publicado: (2019)

Guaiphenesin-ketamine-xylazine infusion to maintain anesthesia in mules undergoing field castration
por: Vullo, Cecilia, et al.
Publicado: (2017)

Effect of intraoperative infusion of ketamine on remifentanil-induced hyperalgesia
por: Choi, Eunji, et al.
Publicado: (2015)

Improvement of Cyclic Vomiting Syndrome with Outpatient Ketamine Infusions
por: Carpenter, Anna, et al.
Publicado: (2021)

(S)-Ketamine but Not (R)-Ketamine Shows Acute Effects on Depression-Like Behavior and Sleep-Wake Architecture in Rats
por: Koncz, Szabolcs, et al.
Publicado: (2023)

3525 Improvement in Suicidal Ideation after Repeated Ketamine Infusions: Relationship to Reductions in Symptoms of Posttraumatic Stress Disorder, Depression, and Pain
por: Albott, Cristina Sophia, et al.
Publicado: (2019)

Ketamine infusion as a sedative-analgesic in severe ARDS (KISS)
por: Pata, Ramakanth, et al.
Publicado: (2021)

Antisuicidal efficacy of ketamine infusion in suicidal patients of depressive disorder
por: Pathak, Umesh, et al.
Publicado: (2021)

Continuous Ketamine Infusion as a Treatment for Refractory Facial Pain
por: Garcia, Roxana, et al.
Publicado: (2023)

Safety of Repeated Administration of Parenteral Ketamine for Depression
por: Feifel, David, et al.
Publicado: (2020)

A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression
por: Phillips, Jennifer L., et al.
Publicado: (2015)

Low-Dose Ketamine Infusion Versus Morphine Infusion During Abdominoplasty to Change the Postoperative Pain Profile
por: Ali, Hassan, et al.
Publicado: (2020)

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
por: Reed, Jessica L., et al.
Publicado: (2018)

Ketamine’s modulation of cerebro-cerebellar circuitry during response inhibition in major depression
por: Loureiro, Joana R.A., et al.
Publicado: (2021)

Ketamine promptly normalizes excess norepinephrine and enhances dopamine neuronal activity in Wistar Kyoto rats
por: Daniels, Stephen, et al.
Publicado: (2023)

Effects of Low-Dose Ketamine Infusion on Alleviating the Opioid Burden for Patients Undergoing Myomectomy Surgery
por: Wahdan, Amr Samir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qb12k5djjj65opmgla9mjebboi